EA200000568A2 - Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы - Google Patents

Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы

Info

Publication number
EA200000568A2
EA200000568A2 EA200000568A EA200000568A EA200000568A2 EA 200000568 A2 EA200000568 A2 EA 200000568A2 EA 200000568 A EA200000568 A EA 200000568A EA 200000568 A EA200000568 A EA 200000568A EA 200000568 A2 EA200000568 A2 EA 200000568A2
Authority
EA
Eurasian Patent Office
Prior art keywords
melatonin
pathologies
treatment
pharmaceutical compositions
prevention
Prior art date
Application number
EA200000568A
Other languages
English (en)
Other versions
EA002823B1 (ru
EA200000568A3 (ru
Inventor
Сонья Пеллиссье
Анн Мерль
Филипп Делагранж
Каролин Беннежан
Пьер Ренар
Original Assignee
Адир Э Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адир Э Компани filed Critical Адир Э Компани
Publication of EA200000568A2 publication Critical patent/EA200000568A2/ru
Publication of EA200000568A3 publication Critical patent/EA200000568A3/ru
Publication of EA002823B1 publication Critical patent/EA002823B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

(57) Применение мелатонина и мелатонинергических лигандов для получения фармацевтических композиций для профилактики и/или лечения патологий желудочно-кишечной системы.
EA200000568A 1999-06-23 2000-06-22 Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы EA002823B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908019A FR2795323B1 (fr) 1999-06-23 1999-06-23 Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal

Publications (3)

Publication Number Publication Date
EA200000568A2 true EA200000568A2 (ru) 2000-12-25
EA200000568A3 EA200000568A3 (ru) 2001-02-26
EA002823B1 EA002823B1 (ru) 2002-10-31

Family

ID=9547206

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000568A EA002823B1 (ru) 1999-06-23 2000-06-22 Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы

Country Status (15)

Country Link
EP (1) EP1064941A1 (ru)
JP (1) JP2001026539A (ru)
KR (1) KR20010039680A (ru)
CN (1) CN1283455A (ru)
AU (1) AU4264800A (ru)
BR (1) BR0002772A (ru)
CA (1) CA2312432A1 (ru)
EA (1) EA002823B1 (ru)
FR (1) FR2795323B1 (ru)
HU (1) HUP0002377A3 (ru)
MX (1) MXPA00006145A (ru)
NO (1) NO20003108L (ru)
NZ (1) NZ505361A (ru)
PL (1) PL340954A1 (ru)
ZA (1) ZA200003165B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2600446C2 (ru) * 2011-10-19 2016-10-20 Универсидад Де Гранада Применение мелатонина для лечения и/или предотвращения мукозита

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249785A1 (en) * 2003-08-13 2005-11-10 Gordon John G Use of melatonin-containing oral supplement with animals
JP4762902B2 (ja) 2003-10-03 2011-08-31 フェーイレン・ナムローゼ・フェンノートシャップ 動物飼料組成物
PT1670444E (pt) 2003-10-03 2011-07-29 Veijlen N V Utilização de derivados do ácido indoleacético que aumentam o nível de igf-1 no soro para a preparação de uma composição terapêutica para o tratamento de várias doenças
TW200803837A (en) * 2006-03-20 2008-01-16 Takeda Pharmaceutical Prophylactic or therapeutic agent for irritable bowel syndrome
RU2693044C1 (ru) * 2018-05-28 2019-07-01 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет) ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеч Способ профилактики нпвп-гастропатии
WO2022157563A1 (en) * 2021-01-23 2022-07-28 Cellix Bio Private Limited A pharmaceutical composition comprising lidocaine and melatonin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2729147A1 (fr) * 1995-01-11 1996-07-12 Adir Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2600446C2 (ru) * 2011-10-19 2016-10-20 Универсидад Де Гранада Применение мелатонина для лечения и/или предотвращения мукозита

Also Published As

Publication number Publication date
HUP0002377A2 (hu) 2002-05-29
EA002823B1 (ru) 2002-10-31
NO20003108L (no) 2000-12-27
EP1064941A1 (fr) 2001-01-03
EA200000568A3 (ru) 2001-02-26
BR0002772A (pt) 2001-01-30
FR2795323B1 (fr) 2001-11-16
MXPA00006145A (es) 2002-10-17
NZ505361A (en) 2002-02-01
AU4264800A (en) 2001-01-04
CN1283455A (zh) 2001-02-14
NO20003108D0 (no) 2000-06-16
KR20010039680A (ko) 2001-05-15
PL340954A1 (en) 2001-01-02
JP2001026539A (ja) 2001-01-30
CA2312432A1 (fr) 2000-12-23
ZA200003165B (en) 2001-01-25
FR2795323A1 (fr) 2000-12-29
HUP0002377A3 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
ATE305306T1 (de) Reboxetin zur behandlung von peripheren neuropathien
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
TWI265808B (en) Valdecoxib compositions
DE69802260T2 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
DE4497905T1 (de) Pharmazeutische Zusammensetzung zur Prävention und Behandlung des Motion-Sickness-Syndroms
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
EA200000568A2 (ru) Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
ATE232390T1 (de) Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs
ATE400277T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
ATE299371T1 (de) Antikonvulsiva zur behandlung von autismus
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
PT1073431E (pt) Utlizacao de antagonistas de nmda no tratamento da sindroma do intestino irritavel
NO20031673D0 (no) Behandling av kreft
DE60007548D1 (de) Omega kettenmodifizierte hydroxyeicosatetraensäure derivate verwendbar in der behandlung der "trockenes auge" krankheit

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU